|
|
|
|
Further delineation of fibrosis progression in NAFLD:
evidence from a large cohort of patients with sequential biopsies
|
|
|
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Stuart McPherson1, Raluca Pais2, Luca Valenti3, Jorn M. Schattenberg4, Jean-Francois Dufour5, Emmanuel Tsochatzis6, Sven Francque7,
Tim Hardy1, Marie Boyle1, Dina Tiniakos1, Vlad Ratziu2, Quentin M. Anstee1 for the EPoS Consortium & European NAFLD Registry Investigators
1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 2Institute of Cardiometabolism and Nutrition, Pitié-Salpêtrière Hospital, Paris, France, 3University of Milan, Milan, Italy, 4Department of Medicine, University Hospital, Mainz, Germany, 5University of Bern, Bern, Switzerland, 6UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom, 7University of Antwerp, Antwerp, Belgium
|
|
|
|
|
|
|